Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
28

Summary

Conditions
  • End Stage Renal Disease
  • Renal Failure
Type
Interventional
Phase
Not Applicable
Design
Intervention Model: Sequential AssignmentIntervention Model Description: prospective, open, controlled, cross-over (with randomized treatment sequences), interventional, multi-centerMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

The primary objective of this study is to test whether the FX P600 is non-inferior to the Xevonta Hi 15 dialyzer and the Elisio 150H dialyzer in removing ?2-microglobulin related to the albumin removal into the dialysate during high volume online hemodiafiltration. The secondary objective of this st...

The primary objective of this study is to test whether the FX P600 is non-inferior to the Xevonta Hi 15 dialyzer and the Elisio 150H dialyzer in removing ?2-microglobulin related to the albumin removal into the dialysate during high volume online hemodiafiltration. The secondary objective of this study is to compare the FX P600 dialyzer with the comparator dialyzers with regard to their efficacies in removing other performance variables (see below). Furthermore, the safety of the FX P600 will be investigated by collecting and analyzing clinical adverse events.

Tracking Information

NCT #
NCT04102280
Collaborators
Institut Dr. Schauerte (IDS)
Investigators
Principal Investigator: Götz Ehlerding, Dr med Zentrum für Nieren-, Hochdruck- und Stoffwechselerkrankungen